β2-microglobulin and CD4/CD8 ratio as HIV-1 markers of maternal transmissibility, neonatal infection and disease progression

Annals of Tropical Paediatrics

Volumn 16, Issue 2, 1996, Pages 155-160

  Moodley, D ^a   Coovadia, H M ^a   Bobat, R A ^a  

^a UNIVERSITY OF NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CD4 ANTIGEN; CD8 ANTIGEN; MARKER;

ADOLESCENT; ADULT; ARTICLE; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MORBIDITY; NEWBORN; NEWBORN INFECTION; VERTICAL TRANSMISSION;

EID: 0029928944     PISSN: 02724936     EISSN: None     Source Type: Journal    
DOI: 10.1080/02724936.1996.11747819     Document Type: Article

References (16)

1. Schwartlander B, Bek B, Skarabis H, Koch J, Burkowitz J, Koch MA. Improvement of the predictive value of CD4 + lymphocyte count, beta 2-microglobulin, immunoglobulin A and erythrocyte sedimentation rate. The Multicentre Cohort Study Group. AIDS 1993; 7:813-21.
2. Alfieri R, Chirianni A, Mancino T, et al. Serum beta 2-microglobulin levels and p24 antigen, lymphocyte depletion and disease progression in human immunodeficiency virus infection. Int J Clin Lab Res 1992; 22:48-51.
3. Stretcher BN, Pesce AJ, Frame PT, Greenberg KA, Stein DS. Correlates of zidovudine phosphorylation with markers of HIV disease progression and drug toxicity. AIDS 1994; 8:763-9.
4. Jackson JB, Kataaha P, Hom DL, et al. Beta 2-microglobulin, HIV-1 p24 antibody and acid dissociated HIV-1 p24 antigen levels: predictive markers for vertical transmission of HIV-1 in pregnant Ugandan women. AIDS 1993; 7:1475-9.
5. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type I with zidovudine treatment. N Engl J Med 1994; 331:1171-80.
6. St Louis ME, Kamenga M, Brown C, et al. Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic and placental factors. JAMA 1993; 269:2853-9.
7. European Collaborative Study. Risk factors for mother-to-child transmission of HIV-1. Lancet 1992; 339:1007-12.
8. Devash Y, Calvelli TA, Wood DG, Reagan KJ, Rubinstein A. Vertical transmission of human immunodeficiency virus is correlated with the absence of high affinity/avidity maternal antibodies to the gp120 principal neutralising domain. Proc Natl Acad Sci USA 1990; 87:3445-9.
9. Dabis F, Msellati P, Dunn D, et al. Estimating the rate of mother-to-child transmission of HIV-1. Report of a workshop on methodological issues, Ghent (Belgium), 17-20 Feb, 1992. AIDS 1993; 7:1139-48.
10. Coutsoudis A, Bobat RA, Coovadia HM, Kuhn L, Tsai W, Stein ZA. The effects of vitamin A supplementation on the morbidity of children born to HIV-infected women. Am J Public Health 1995; 85:1076-81.
11. Ellaurie M, Rubinstein A. Beta 2-microglobulin concentrations in pediatric human immunodeficiency virus infection. Pediatr Infect Dis J 1990; 9:807-9.
12. Monforte AA, Ravizza M, Muggiasca ML, et al. Maternal predictors of HIV vertical transmission. Eur J Obstet Gynaecol Reprod Biol 1991; 42:131-6.
13. Erb P, Krauchi S, Burgin D, Biedermann K, Camli C, Rudin C. Quantitative anti-p24 determinations can predict the risk of vertical transmission. Swiss HIV and Pregnancy Collaborative Study Group. J Acq Immuno Def Synd 1994; 7:261-4.
14. Lafevillade A, Tamalet C, Pellegmino P, de Miuo P, Vignoli C, Quilichini R. Correlation between surrogate markers, viral load and disease progression in HIV-1 infection. J Acq Immuno Def Synd 1994; 7:1028-33.
15. Blanche S, Tardieu M, Duliege AM, et al. Longitudinal study of 94 symptomatic infants with perinatally-acquired human immunodeficiency virus infection: evidence for a bimodal expression of clinical and biological symptoms. Am J Dis Child 1990; 144:1210-15.
16. Mulder JW, Krijnen P, Coutinno RA, Balker M, Goudsmit J, Lange JM. Serum beta 2-microglobulin levels in asymptomatic HIV-1 infected subjects during long-term zidovudine treatment. Genitourin Med 1992; 67:188-93.